View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Axalta Schedules Third Quarter 2025 Earnings Conference Call

Axalta Schedules Third Quarter 2025 Earnings Conference Call PHILADELPHIA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, will release its third quarter 2025 financial results at 6 a.m. ET on Tuesday, October 28. The release and supporting materials will be posted to . In addition, the company will host a conference call at 8 a.m. ET on October 28. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the period. A live webcas...

 PRESS RELEASE

Axalta Unveils Innovative Coatings to Support Improved Battery Safety ...

Axalta Unveils Innovative Coatings to Support Improved Battery Safety in Electric Vehicles New coating solutions engineered for extreme heat protection and better electrical insulation for EV battery applications PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, today will unveil two innovative products at The Battery Show North America (Booth #1638), reinforcing its commitment to innovation, technical service and performance in energy storage solutions and the automotive industry value chain. The new products, Alesta® e-PRO FG Black and A...

 PRESS RELEASE

Dr. Delson Trindade Elevated to Axalta Fellow

Dr. Delson Trindade Elevated to Axalta Fellow Becoming an Axalta Fellow is the highest honor a scientist or engineer can earn within Axalta’s Global Technology Function PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, has elevated Dr. Delson Trindade to the position of Axalta Fellow, as a result of his significant scientific accomplishments, technical leadership, and commercial contributions throughout his distinguished career at Axalta. Axalta Fellow is the highest honor that a scientist or engineer can earn within the company’s Global ...

 PRESS RELEASE

Aspen Aerogels, Inc. Appoints Glenn Deegan as Chief Administrative Off...

Aspen Aerogels, Inc. Appoints Glenn Deegan as Chief Administrative Officer Seasoned executive brings 25+ years of legal, HR, and transactional leadership to Aspen’s executive team NORTHBOROUGH, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company"), a technology leader in sustainability and thermal management solutions, today announced the appointment of Glenn Deegan as Chief Administrative Officer. Mr. Deegan will report directly to President and Chief Executive Officer Don Young and will be based at the company’s Aerogel Technology Cente...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: September 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Aspen Aerogels, Inc. to Participate in the Barclays 39th Annual Energy...

Aspen Aerogels, Inc. to Participate in the Barclays 39th Annual Energy-Power Conference NORTHBOROUGH, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the 39th Annual Barclays Energy-Power Conference on Wednesday, September 3, to be held at the Sheraton Times Square Hotel in New York, NY. Ricardo C. Rodriguez, Chief Financial Officer & Treasurer, and Neal Baranosky, Senior Director, Head of Investor Rela...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Mid-America Apartments, L.P. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 August 2025 in which we reassessed the appropriateness of the ratings in th...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 9, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Opko Health Inc: 1 director

A director at Opko Health Inc bought 675,000 shares at 1.320USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and...

Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights $78 million in quarterly revenue resulted in 32% gross margins and ~2X Adjusted EBITDA improvement QoQCFO transition to internal successor during Q3 ensures continuation of strategic direction and executionFixed cost structure reductions are expected to drive incremental profit in the second half of the year NORTHBOROUGH, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification ...

 PRESS RELEASE

Aspen Aerogels to Participate in August Investor Conferences

Aspen Aerogels to Participate in August Investor Conferences NORTHBOROUGH, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the following investor events in August: (i) Oppenheimer 28th Annual Technology, Internet & Communications Conference, and (ii) Canaccord Genuity 45th Annual Growth Conference. The presentation materials utilized during the conferences will be available on the Investor Relations sect...

 PRESS RELEASE

OPKO Health Reports Second Quarter 2025 Business Highlights and Financ...

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: Merck advanced Phase 1 Epstein-Barr virus vaccine trial (). This investigational vaccine candidate is being developed in collaboration with Merck and evaluates safety and tolerability in up to 200 h...

 PRESS RELEASE

Axalta Releases Second Quarter 2025 Results

Axalta Releases Second Quarter 2025 Results PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights: Second quarter net sales of $1.3 billionNet income of $110 million with a net income margin of 8.4%Record quarter for Adjusted EBITDA of $292 millionAdjusted EBITDA margin expanded 90 basis points year over year to 22.4%Diluted EPS decreased 2% to $0.50Record quarter for Adjusted Diluted EPS of $0.64, an ...

 PRESS RELEASE

OPKO Health to Report Second Quarter 2025 Financial Results on July 31

OPKO Health to Report Second Quarter 2025 Financial Results on July 31 MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-re...

 PRESS RELEASE

Aspen Aerogels, Inc. Schedules Second Quarter 2025 Earnings Release an...

Aspen Aerogels, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call NORTHBOROUGH, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Ricardo C. Rodriguez, Chief Financial Officer & Treasurer, expect to discuss the Company's financial results for the second quarter ended June 30, 2025, during a conference call scheduled for Thursday, August 7, 2025, at 8:30 a.m. ET. The Company also expects to release its quarterly financial results before the mark...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 12, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Axalta Schedules Second Quarter 2025 Earnings Conference Call

Axalta Schedules Second Quarter 2025 Earnings Conference Call PHILADELPHIA, July 08, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its second quarter 2025 financial results at 6 a.m. ET on Wednesday, July 30. The release and supporting materials will be posted to . In addition, the company will host a conference call at 8 a.m. ET on July 30. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the p...

 PRESS RELEASE

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Ta...

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has been selected for a poster presentation at the 47th European Society for Clinical Nutrition & Metabolism (“ESPEN”) Congress, taking place September 13–16, 2025, in Prague, Czech Republic. A...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 5, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch